CASE REPORT
Paraneoplastic systemic sclerosis associated with colorectal carcinoma
More details
Hide details
Submission date: 2018-04-20
Final revision date: 2018-05-23
Acceptance date: 2018-06-25
Online publication date: 2018-06-30
Publication date: 2018-08-31
Reumatologia 2018;56(3):194-198
KEYWORDS
TOPICS
ABSTRACT
A number of rheumatic disorders may appear as paraneoplastic syndromes, the most common being dermatomyositis or polymyositis. Systemic sclerosis is associated with a slightly increased risk of cancer, although its direct association with malignancies is controversial. We describe a case of a 57-year-old male with rectal adenocarcinoma and systemic sclerosis. Close temporal relationship between the initial presentation and parallel course of both conditions, as well as atypically rapid progression of systemic sclerosis symptoms, were observed in the reported case. The strict relation between these two conditions suggested that systemic sclerosis was a paraneoplastic syndrome rather than a concomitant morbidity in the presented patient. Current literature on systemic sclerosis coexisting with colorectal tumours is very limited, especially in the paraneoplastic setting.
REFERENCES (19)
1.
Salazar G, Mayes MD. Genetics, epigenetics, and genomics of systemic sclerosis. Rheum Dis Clin North Am 2015; 41: 345-366.
2.
Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993; 36: 46-54.
3.
Airo’ P, Ceribelli A, Cavazzana I, et al. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. J Rheumatol 2011; 38: 1329-1334.
4.
Onishi A, Sugiyama D, Kumagai S, et al. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 2013; 65: 1913-1921.
5.
Baijens LW, Manni J. Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature. J Eur Arch Otorhinolaryngol 2006; 263: 32-36.
6.
van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-2747.
7.
Fam AG. Paraneoplastic rheumatic syndrome. Best Pract Res Clin Rheumatol 2000; 14: 515-533.
8.
Świerkot J, Lewandowicz-Uszyńska A, Bogunia-Kubik K. Zespoły paranowotworowe a choroby reumatyczne. Postepy Hig Med Dosw 2014; 68: 944-954.
9.
Nathanson L, Hall TC. Introduction: paraneoplastic syndromes. Semin Oncol 1997; 24: 265-268.
10.
Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976; 84: 68-76.
11.
Shah AA, Hummers LK, Casciola-Rosen L, et al. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma. Arthritis Rheumatol 2015; 67: 1053-1061.
12.
Shah AA, Xu G, Rosen A, et al. Anti-RNPC-3 antibodies as a marker of cancer-associated scleroderma. Arthritis Rheumatol 2017; 69: 1306-1312.
13.
Kupfer I, Balguerie X, Courville P, et al. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol 2003; 48: 279-281.
14.
Fujii T, Mimori T, Kimura N, et al. Pseudoscleroderma associated with transforming growth factor beta 1-producing advanced gastric carcinoma: comment on the article by Varga. Arthritis Rheum 2003; 48: 1766-1767.
15.
Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy – is there an association? Scand J Rheumatol 2001; 30: 185-188.
16.
Olesen AB, Svaerke C, Farkas DK, et al. Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 2010; 163: 800-806.
17.
Shah AA, Casciola-Rosen L. Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening. Curr Opin Rheumatol 2015; 27: 563-570.
18.
Shah AA, Rosen A, Hummers L, et al. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum 2010; 62: 2787-2795.
19.
Zeineddine N, Khoury LE, Mosak J. Systemic Sclerosis and Malignancy: A Review of Current Data. J Clin Med Res 2016; 8: 625-632.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.